Tenax Therapeutics (TENX US)

Analysis

Health Care • United States

Tenax Therapeutics, Inc. operates as a specialty pharmacuitical company. The Company develops and commercializes products for the critical care market. Tenax Therapeutics develops treatments for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF) using levosimendan.

Refresh

Company Presentation • 09 Sep 2026 20:35

12th Annual Cantor Fitzgerald Global Healthcare Conference

Company Presentation • 10 Aug 2026 20:00

Study result

Company Presentation • 10 Mar 2026 19:00

Corporate presentation

Company Presentation • 26 Jun 2025 19:00

Corporate Presentation

Company Presentation • 05 Mar 2025 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00